<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32123192</article-id>
<article-id pub-id-type="pmc">7052240</article-id>
<article-id pub-id-type="publisher-id">60266</article-id>
<article-id pub-id-type="doi">10.1038/s41598-020-60266-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The unique expression profile of <italic>FAM19A1</italic> in the mouse brain and its association with hyperactivity, long-term memory and fear acquisition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yong</surname>
<given-names>Hyo Jeong</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ha</surname>
<given-names>Nui</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Eun Bee</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yun</surname>
<given-names>Seongsik</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyun</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0729-1782</contrib-id>
<name>
<surname>Hwang</surname>
<given-names>Jong-Ik</given-names>
</name>
<address>
<email>hjibio@korea.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seong</surname>
<given-names>Jae Young</given-names>
</name>
<address>
<email>jyseong@korea.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0840 2678</institution-id><institution-id institution-id-type="GRID">grid.222754.4</institution-id><institution>The GPCR laboratory, Graduate School of Biomedical Science, </institution><institution>Korea University College of Medicine, </institution></institution-wrap>Seoul, 02841 Republic of Korea </aff>
<aff id="Aff2"><label>2</label>Neuracle Science Co. Ltd., Seoul, 02841 Republic of Korea </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0840 2678</institution-id><institution-id institution-id-type="GRID">grid.222754.4</institution-id><institution>Department of Anatomy, </institution><institution>Korea University College of Medicine, </institution></institution-wrap>Seoul, 02841 Republic of Korea </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>10</volume>
<elocation-id>3969</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Neurodevelopment and mature brain function are spatiotemporally regulated by various cytokines and chemokines. The chemokine-like neuropeptide FAM19A1 is a member of family with sequence similarity 19 (FAM19), which is predominantly expressed in the brain. Its highly conserved amino acid sequence among vertebrates suggests that FAM19A1 may play important physiological roles in neurodevelopment and brain function. Here we used a <italic>LacZ</italic> reporter gene system to map the expression pattern of the <italic>FAM19A1</italic> gene in the mouse brain. The <italic>FAM19A1</italic> expression was observed in several brain regions starting during embryonic brain development. As the brain matured, the <italic>FAM19A1</italic> expression was detected in the pyramidal cells of cortical layers 2/3 and 5 and in several limbic areas, including the hippocampus and the amygdala. FAM19A1-deficient mice were used to evaluate the physiological contribution of FAM19A1 to various brain functions. In behavior analysis, FAM19A1-deficient mice exhibited several abnormal behaviors, including hyperactive locomotor behavior, long-term memory deficits and fear acquisition failure. These findings provide insight into the potential contributions of FAM19A1 to neurodevelopment and mature brain function.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Neuronal development</kwd>
<kwd>Developmental disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003725</institution-id>
<institution>National Research Foundation of Korea (NRF)</institution>
</institution-wrap>
</funding-source>
<award-id>NRF-2016R1A2B1010036</award-id>
<principal-award-recipient>
<name>
<surname>Hwang</surname>
<given-names>Jong-Ik</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Developmental and physiological processes in the central nervous system (CNS) are tightly regulated by a series of orchestrated gene expressions to promote the formation of dynamic neural circuitries and to execute diverse brain functions<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. These gene expressions are heavily influenced by numerous extrinsic factors, including secretory signaling molecules, extracellular matrix proteins, and membrane-bound signaling proteins. In particular, several types of secretory proteins are produced by brain cells and play crucial roles in biological processes in the CNS, including neurogenesis and synaptic plasticity<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
<p id="Par3">Cytokines and chemokines are secretory proteins that mediate a diverse range of functions in the CNS<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. In neural induction process, cytokines are known to act as regulators in the self-renewal of neural stem cells (NSCs) and progenitor differentiation<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Moreover, chemokines, a subclass of cytokines, are involved in neural development. For instance, C-X-C motif chemokine 12 (CXCL12) regulates neural migration and axon pathfinding via the C-X-C chemokine receptor type 4 (CXCR4) signaling pathway<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Furthermore, in the adult nervous system, cytokines such as leukemia inhibitory factor (LIF) control neurotransmitter and neuropeptide profiles<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>, whereas interleukin-1 beta (IL-1β) modulates the activity of local neural networks via reconstructing synaptic plasticity and intercellular communication<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. Taken together, these findings indicate that the normal development and physiological functions within the CNS depend on the spatiotemporal regulation of several cytokines and chemokines. Given emerging evidence that abnormal cytokine profiles are associated with neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit hyperactive disorder (ADHD), it is important to understand the biological functions of these small secretory proteins in the CNS<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>.</p>
<p id="Par4">Family with sequence similarity 19 (FAM19) is a chemokine-like peptide family composed of five highly homologous genes, <italic>FAM19A1</italic> to <italic>FAM19A5</italic>. These genes are well conserved across species with specific expression patterns in the CNS<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Recent studies have shown that FAM19A2 may function as a neurotrophic factor with important roles in social novelty preference, anxiety response and neural survival<sup><xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref></sup>. FAM19A4 modulates mechanical and chemical-induced hypersensitivity via the regulation of neuronal excitability<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. In <italic>FAM19A3</italic> knock-out mice, ASD-like phenotypes are observed, including increased anxiety and repetitive behaviors<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Furthermore, a recent study reports that FAM19A1 may regulate the proliferation and differentiation of NSCs, which implies a possible important role of FAM19A1 in brain development and neurogenesis<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>.</p>
<p id="Par5">In this study, we generated <italic>FAM19A1 LacZ</italic> knock-in (KI) mice to investigate the potential roles of FAM19A1 in the brain. We demonstrated that <italic>FAM19A1</italic> is expressed in early stages of brain developmental with restricted expression patterns. We further demonstrated that this expression expands throughout the cortex in a cortical layer-dependent manner as the brain matures. Moreover, in the mature brain, <italic>FAM19A1</italic> is expressed in various regions of the limbic system. We also conducted behavioral analyses, showing that FAM19A1-deficient mice exhibit locomotor hyperactivity and deficits in long-term memory and fear acquisition. These findings suggest that FAM19A1 may be involved in both neurodevelopment and important brain functions.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>Generation of <italic>LacZ</italic>-expressing <italic>FAM19A1</italic> knock-out mice</title>
<p id="Par6"><italic>FAM19A1 LacZ</italic> KI mice were generated to investigate the role of FAM19A1 in the brain. The <italic>LacZ</italic> gene encoding β-galactosidase was inserted immediately after the translational start codon in exon 2 of the <italic>FAM19A1</italic> gene to ensure β-galactosidase production when and where <italic>FAM19A1</italic>is expressed (Fig. <xref ref-type="fig" rid="Fig1">1A</xref>). The <italic>FAM19A1 LacZ</italic> KI mice used in this experiment were validated by genomic DNA PCR using primers specifically targeting the inserted <italic>LacZ</italic> gene sequence (Fig. <xref ref-type="fig" rid="Fig1">1B</xref>). Given that the inserted <italic>LacZ</italic> gene sequence has its own stop codon as well as a poly-A tail, the final product of this gene construct is the intact β-galactosidase without any parts of FAM19A1. Disruption of the <italic>FAM19A1</italic> gene in <italic>FAM19A1 LacZ</italic> KI mice was confirmed by RT-PCR (Fig. <xref ref-type="fig" rid="Fig1">1C</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Gene construct and validation of <italic>FAM19A1 LacZ</italic> knock-in (KI) mice. (<bold>A</bold>) Schematic diagram of the <italic>FAM19A1 LacZ</italic> KI mouse gene construct. F UP1 is the forward primer and FWT dn1 and FKI dn2 are the reverse primers for the genotyping. (<bold>B</bold>) Genotypes of <italic>FAM19A1 LacZ</italic> KI mice were determined by genomic DNA PCR using primers targeting the inserted <italic>LacZ</italic> gene. (<bold>C</bold>) Detection of <italic>FAM19A1</italic> mRNA in the mouse CTX and HIP tissues by RT-PCR using primers targeting exon 2 and exon 5 of <italic>FAM19A1</italic>. (<bold>D</bold>) Detection of endogenous FAM19A1 protein in the mouse CTX and HIP tissue lysates using FAM19A1 specific antibody. Exposure time during development with ECL solution; 30 min for FAM19A1 and 1 min for β-actin. (<bold>E</bold>,<bold>F</bold>) FAM19A1 protein expression level in +/− (n = 3) and −/− (n = 3) against WT (n = 3) from western blot analysis. (<bold>G</bold>) Detection of <italic>FAM19A1</italic> mRNA and FAM19A1 protein in various WT mouse brain regions by RT-PCR and western blotting. Exposure time during development with ECL solution; 30 min for FAM19A1 and 1 min for β-actin. (<bold>H</bold>) FAM19A1 protein expression level in various brain regions relative to CTX of WT mice (n = 3). E1, exon 1; E2, exon 2; E3, exon 3; E4, exon 4; E5, exon 5; <italic>lacZ</italic>, <italic>lacZ</italic> gene; <italic>neo</italic>, amino 3′-glycosyl phosphotransferase gene; pA, poly-A tail; WT, wild type mouse; +/−, heterozygous <italic>FAM19A1 LacZ</italic> KI; −/−, homozygous <italic>FAM19A1 LacZ</italic> KI; CTX, cortex; HIP, hippocampus; OB, olfactory bulb; CB, cerebellum; TH, thalamus; HYP, hypothalamus; MB, midbrain; PO, pons; a.u., arbitrary unit. Data are presented as means ± standard errors of the means (SEM). **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 versus WT by one-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> tests. Full-length gels and blots are presented in Supplementary Fig. <xref ref-type="media" rid="MOESM1">S1</xref> for panels B, C and D and S3 for panel G.</p></caption><graphic id="d29e524" xlink:href="41598_2020_60266_Fig1_HTML"></graphic></fig></p>
<p id="Par7">To validate FAM19A1 protein expression, tissue extracts of the cortex and hippocampus were analyzed by western blotting with in-house made FAM19A1-specific antibody (Fig. <xref ref-type="fig" rid="Fig1">1D–F</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S2</xref>). FAM19A1 was determined in wild-type (WT) mice, whereas its level was substantially decreased in heterozygous mice and was not detected in homozygous mice. In addition, it was confirmed that FAM19A1 protein was abundant where its mRNA expression was high (Fig. <xref ref-type="fig" rid="Fig1">1G,H</xref>).</p>
</sec>
<sec id="Sec4">
<title><italic>FAM19A1</italic> gene expression in the developing mouse brain</title>
<p id="Par8">To investigate the possible involvement of FAM19A1 during neurodevelopment, the expression patterns of <italic>FAM19A1</italic> in embryonic and postnatal mouse brains were visualized. Because the <italic>FAM19A1 LacZ</italic> KI mouse was designed to express β-galactosidase instead of FAM19A1, the expression pattern of <italic>FAM19A1</italic> could be traced by enzymatic activity of β-galactosidase via X-gal staining. Heterozygous mice were used to analyze the expression patterns, which may avoid a potential abnormality of mice due to the complete ablation of the FAM19A1 protein.</p>
<p id="Par9">There was no sign of <italic>FAM19A1</italic> expression through embryonic day 12.5 (E12.5; Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4A</xref>). Starting from embryonic day 14.5 (E14.5), β-galactosidase activity was observed in the piriform cortex (CPf) and the entorhinal cortex (CEn) (Fig. <xref ref-type="fig" rid="Fig2">2A</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4B</xref>). Neocortical expression of β-galactosidase was seen after birth and gradually expanded to other regions as postnatal age increased (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4C</xref>). By postnatal day 14.5 (P14.5), neocortical β-galactosidase expression was found in a cortical layer-specific manner (Fig. <xref ref-type="fig" rid="Fig2">2B</xref>). In addition, X-gal staining signals were detected in the limbic areas, including the posteromedial cortical amygdaloid nucleus (PMCo), the hippocampus and the amygdala (Fig. <xref ref-type="fig" rid="Fig2">2B</xref>). These results provide preliminary evidence that FAM19A1 is likely expressed in differentiated neuronal cells during neurodevelopment, as <italic>FAM19A1</italic> expression patterns were specifically confined to the cortical layers and regions of the limbic system. In addition, <italic>FAM19A1</italic> was not detected in stem-cell rich regions, such as the ventricular zone or the subventricular zone, suggesting that FAM19A1 may not be involved in the proliferation of NSCs.<fig id="Fig2"><label>Figure 2</label><caption><p>X-gal staining of embryonic and postnatal <italic>FAM19A1 LacZ</italic> knock-in (KI) (+/−) mouse brains. (<bold>A</bold>) Detection of X-gal signals in the coronal brain sections at E14.5 and E18.5. (<bold>B</bold>) X-gal staining of postnatal mouse brains. ACo, anterior cortical amygdaloid nucleus; Amy, amygdala; AO, anterior olfactory nucleus; Au, auditory cortex; BMA; basomedial amygdaloid nucleus, anterior part; CEn, entorhinal cortex; CPf, piriform cortex; FR, fasciculus retroflexus; Hip, hippocampus; LS, lateral septal nucleus; M, motor cortex; MGV, medial geniculate nucleus, ventral part; Op, optic nerve layer of the superior colliculus; PF, pontine flexure; PMCo, posteromedial cortical amygdaloid nucleus; Pn, pontine nuclei; PrL, prelimbic cortex; RMC, red nucleus, magnocellular part; S, somatosensory cortex; V, visual cortex. Scale bars represent 500 μm in panels A and B.</p></caption><graphic id="d29e599" xlink:href="41598_2020_60266_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec5">
<title><italic>FAM19A1</italic>gene expression in the adult mouse brain</title>
<p id="Par10">Given the recent evidence that cytokines are important mediators in normal neural activities<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, it was hypothesized that FAM19A1 may play a critical role in various neural circuits. To understand the putative contribution of FAM19A1 in mature brain functions, the expression pattern of <italic>FAM19A1</italic> was mapped in adult <italic>FAM19A1 LacZ</italic> KI heterozygous mice.</p>
<p id="Par11">In the adult mouse brain, X-gal staining indicated that <italic>FAM19A1</italic> was expressed in all cortical areas (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4C</xref>). Immunohistochemistry with X-gal staining showed that X-gal precipitates and β-galactosidase were co-localized with CUX1, a pyramidal neuronal marker for cortical layers 2–3 (L2-3)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> and CTIP2, a pyramidal neuronal marker for cortical layer 5b (L5b)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, respectively. This indicates that<italic> FAM19A1</italic>is expressed mainly in pyramidal neurons in a layer-specific manner (Fig. <xref ref-type="fig" rid="Fig3">3A,B,F</xref>). X-gal signals in the corticospinal tract, including the internal capsule (ic), the cerebral peduncle (cp) and the pyramidal tract (py) may further support the presence of FAM19A1 in the pyramidal neurons of primary motor cortical L5b (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5H,I</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>Expression pattern of <italic>FAM19A1</italic> in the adult mouse brain. (<bold>A</bold>) X-gal precipitates (red) were detected in the subset of cortical L2-3 CUX1-positive neurons (green) in <italic>FAM19A1 LacZ</italic> KI mice. (<bold>B</bold>) β-galactosidase (green) were identified in the subset of cortical L5 CTIP2-positive neurons (magenta) in <italic>FAM19A1 LacZ</italic> KI mice. Arrowheads indicate X-gal or β-galactosidase expressing cortical marker cells. (<bold>C</bold>–<bold>K</bold>) X-gal staining in the coronal brain sections of a <italic>FAM19A1 LacZ</italic> KI (+/−) mouse. AO, anterior olfactory nucleus; Apir, amygdalopiriform transition area; BLA, basomedial amygdaloid nucleus; BLP, basolateral amygdaloid nucleus, posterior part; CEn, entorhinal cortex; CPf, piriform cortex; D3V, dorsal 3rd ventricle; FrA, frontal association cortex; L2-3, cortical layer 2-3; L5, cortical layer 5; CA1, 2 and 3, field of CA1, CA2 and CA3 regions of the hippocampus; LaDL, lateral amygdaloid nucleus; LHb, lateral habenular nucleus; LO, lateral orbital cortex; LS, lateral septal nucleus; LV, lateral ventricle; MGN, medial geniculate nucleus; MO, medial orbital cortex; Op, optic nerve layer of the superior colliculus; PMCo, posteromedial cortical amygdaloid nucleus; PrL, prelimbic cortex; Py, pyramidal cell layer of the hippocampus; RG, retrosplenial granular cortex; VO, ventral orbital cortex. Scale bars represent 100 μm in panel A and 500 μm in panels (<bold>C</bold>–<bold>K</bold>).</p></caption><graphic id="d29e685" xlink:href="41598_2020_60266_Fig3_HTML"></graphic></fig></p>
<p id="Par12">The presence of FAM19A1 in specific sensory circuits was also investigated. In the olfactory neural circuitry, β-galactosidase and <italic>FAM19A1</italic> mRNA expressions were hardly observed in the olfactory bulbs (Fig. <xref ref-type="fig" rid="Fig1">1G</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5A</xref>), but FAM19A1 proteins were detected by western blotting (Fig. <xref ref-type="fig" rid="Fig1">1G</xref>). Detected FAM19A1 proteins might be released from neurons of other olfaction-related brain regions including the anterior olfactory nucleus (AO), the CPf, and the cortical amygdala that exhibited positive X-gal signals (Fig. <xref ref-type="fig" rid="Fig3">3D,E,H</xref>). For the visual neural circuit, there was no β-galactosidase expression in the optic chiasm or the lateral geniculate nucleus (LGN) of the visual neural circuit, but the optic layer of the superior colliculus (Op) and the visual cortex both exhibited β-galactosidase expression (Fig. <xref ref-type="fig" rid="Fig3">3I</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S4C</xref>), indicating that FAM19A1 may be involved in superior colliculus-dependent visual information processing and ocular motor control. The β-galactosidase expression was also observed in some regions associated with the auditory neural circuit, including the medial geniculate nucleus (MGN), the dorsal cochlear nucleus (DC) and the auditory cortex (Fig. <xref ref-type="fig" rid="Fig3">3K</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5F</xref>).</p>
<p id="Par13">There was notable expression of <italic>FAM19A1</italic> in the limbic regions, including the hippocampus and the amygdala. In the hippocampus, β-galactosidase was expressed in the CA regions but not in the dentate gyrus (DG) (Fig. <xref ref-type="fig" rid="Fig3">3F</xref>). Previous report claimed that FAM19A1 protein was detected in both CAs and DG of the hippocampus using immunohistochemistry<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Open-source single cell RNA sequencing database supports our expression pattern showing lack of <italic>FAM19A1</italic> expression in the DG<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. However, FAM19A1 as being a secretory protein, there is a possibility that FAM19A1 protein might be detected in non-<italic>FAM19A1</italic> gene expressing brain regions. With the β-galactosidase expression in the CEn, hippocampal <italic>FAM19A1</italic> expression suggests its possible participation in the hippocampal trisynaptic circuit (Fig. <xref ref-type="fig" rid="Fig3">3F,J</xref>). Among the amygdaloidal nuclei, β-galactosidase was expressed exclusively in the basolateral nuclei, including the lateral amygdaloid nucleus (LaDL) and the basomedial amygdaloid nucleus (BLA) (Fig. <xref ref-type="fig" rid="Fig3">3G</xref>). In addition, <italic>FAM19A1</italic> expression was detected in the PMCo and the amygdalopiriform transition area (Apir) (Fig. <xref ref-type="fig" rid="Fig3">3H</xref>), which have direct connections with the BLA, the CEn and the CPf <sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p>
<p id="Par14">The β-galactosidase was expressed in some hypothalamic nuclei, including the medial preoptic nucleus (MPOM), the lateral preoptic area (LPO) and the ventromedial hypothalamic nucleus (VMH) (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5B,C</xref>). As a part of the limbic system, the hypothalamus acts as a mediator between the CNS and the endocrine system<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. FAM19A1 may therefore contribute to endocrine homeostasis. The lateral septal nucleus (LS), another brain region extensively connected to the limbic areas also had the β-galactosidase expression (Fig. <xref ref-type="fig" rid="Fig3">3E</xref>)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
<p id="Par15"><italic>In situ</italic> hybridization using the adult wild type rat brain showed that <italic>FAM19A1</italic> mRNAs were detected in the upper and lower cortical layers, the CA regions of the hippocampus and the basolateral nuclei of the amygdala (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S6A</xref>). These <italic>FAM19A1</italic> mRNA expression patterns coincided with the expression pattern of β-galactosidase in the <italic>FAM19A1 LacZ</italic> KI mouse brain, providing credibility to <italic>FAM19A1</italic> expression mapping using <italic>FAM19A1 LacZ</italic> KI mice (Fig. <xref ref-type="fig" rid="Fig3">3D,F,G</xref>). Moreover, our <italic>FAM19A1</italic> expression pattern highly agrees with open-source single cell-based RNA-sequencing database for WT mouse brain<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Taken together, these data indicate that <italic>FAM19A1</italic> is mainly expressed in neurons, particularly in pyramidal neurons, and is likely to be involved in motor behavior, sensory information processing and limbic system-related brain functions.</p>
</sec>
<sec id="Sec6">
<title>Morphological differences between WT and <italic>FAM19A1</italic> −/− mouse brains</title>
<p id="Par16">Early deficiency of FAM19A1 may cause developmental abnormalities in the brain. Morphological differences in homozygous <italic>FAM19A1 LacZ</italic> KI (<italic>FAM19A1</italic> −/−), heterozygous <italic>FAM19A1 LacZ</italic> KI (<italic>FAM19A1</italic> +/−) and WT mice were investigated.</p>
<p id="Par17">For general features, <italic>FAM19A1</italic> −/− mice were born with approximately 24–25% of Mendelian frequency and similar sex-ratio from the heterozygous parents (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S6B</xref>). There were no notable differences in the gross appearance between newborn genotypes immediately after birth; however, it was observed that <italic>FAM19A1</italic> −/− mice were weighed significantly less than WT mice (Fig. <xref ref-type="fig" rid="Fig4">4A,B</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Differences in body weight and gross brain size between adult WT and <italic>FAM19A1 LacZ</italic> knock-in (KI) mice. (<bold>A</bold>) Changes in body weight with age in male <italic>FAM19A1 LacZ</italic> KI mice; F(2, 450) = 189.5, <italic>p</italic> &lt; 0.0001 across genotypes. (<bold>B</bold>) Changes in body weight with age in female <italic>FAM19A1 LacZ</italic> KI mice; F(2, 198) = 71.07, <italic>p</italic> &lt; 0.0001 across genotypes. (<bold>C</bold>) Whole-mount view of the WT and <italic>FAM19A1</italic> (−/−) adult mouse brains. (<bold>D</bold>–<bold>F</bold>) Total brain length, cerebral cortical length and brain width, respectively, of WT (n = 9), <italic>FAM19A1</italic> +/− (n = 8) and <italic>FAM19A1</italic> −/− (n = 8) adult mouse brains. For panel E, F(2, 22) = 10.04, <italic>p</italic> = 0.0008. (<bold>G</bold>) Motor cortical layers in the Nissl-stained brain tissues of WT and <italic>FAM19A1 LacZ</italic> KI mice. (<bold>H</bold>–<bold>J</bold>) Cortical thickness of the motor (F(2, 11)= 2.363, <italic>p</italic> = 0.1401), somatosensory (F(2, 11) = 3.652, <italic>p</italic> = 0.0608) and visual cortex (F(2, 11) = 3.911, <italic>p</italic> = 0.0521), respectively, of WT (n = 5), <italic>FAM19A1</italic> +/− (n = 5) and <italic>FAM19A1</italic> −/− (n = 4) adult mice. Scale bars represent 2 mm in panel C and 200 μm in panel G. Data are presented as means ± standard errors of the means (SEM). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 versus WT or <italic>FAM19A1</italic> +/− by one-way or two-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> tests.</p></caption><graphic id="d29e941" xlink:href="41598_2020_60266_Fig4_HTML"></graphic></fig></p>
<p id="Par18">The total length and width of adult brains were similar between WT and <italic>FAM19A1</italic> −/− mice (Fig. <xref ref-type="fig" rid="Fig4">4C,D,F</xref>), whereas the cerebral cortical length was longer in <italic>FAM19A1</italic> −/− mice compared to WT mice (Fig. <xref ref-type="fig" rid="Fig4">4E</xref>). Ablation of genes specifically expressed in the cortical layer often leads to improper cortical layer assembly<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. However, cerebral cortical volume remained unaffected (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S7</xref>). In addition, there were no notable structural abnormalities in brain architecture detected by gross observations on the X-gal stained brain sections of <italic>FAM19A1</italic> −/− mice (data not shown). The thickness of all neocortical areas was not significantly reduced in <italic>FAM19A1</italic> −/− mice (Fig. <xref ref-type="fig" rid="Fig4">4H,I,J</xref>). In terms of cortical layer proportion, however, L4 in visual cortex and L6 in motor cortex were decreased in <italic>FAM19A1</italic> −/− compared to WT mice (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S8</xref>).</p>
<p id="Par19">While these changes in cortical layer thickness could be the result of abnormal cytoarchitecture, no significant differences in the neuronal and glial cell populations of the cortical layers were observed between the <italic>FAM19A1</italic> −/− and WT mice (Supplementary Figs. <xref ref-type="media" rid="MOESM1">S9</xref> and <xref ref-type="media" rid="MOESM1">S10</xref>). In addition, there were no notable abnormalities in morphology of neuronal and glial cells (Data not shown). Taken together, these findings indicate that global <italic>FAM19A1</italic> ablation reduced body weight gain and mildly altered the neocortical architecture but did not significantly impact cell type composition of the cortex.</p>
</sec>
<sec id="Sec7">
<title>FAM19A1-deficient mice displayed hyperactive behavior</title>
<p id="Par20">Several behavior tests were performed in <italic>FAM19A1 LacZ</italic> KI mice to investigate the effect of FAM19A1 depletion on behavior. <italic>FAM19A1</italic> is expressed in several areas of the limbic system including the prelimbic cortex and the amygdala (Fig. <xref ref-type="fig" rid="Fig3">3C,G</xref>), which are known to be involved in emotional processing<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. To evaluate the effects of FAM19A1 depletion on anxiety and depression, the elevated plus maze (EPM) test, the open field test (OFT), and the tail suspension test (TST) were performed. On the EPM test, the amount of time spent in the open arms (Fig. <xref ref-type="fig" rid="Fig5">5A</xref>) and the total distance travelled increased (Fig. <xref ref-type="fig" rid="Fig5">5B</xref>) in <italic>FAM19A1</italic> −/− mice compared to WT mice. On the OFT, the amount of time spent in the center of the OFT arena was similar between <italic>FAM19A1</italic> −/− and WT mice, but the total distance travelled was higher in <italic>FAM19A1</italic> −/− mice (Fig. <xref ref-type="fig" rid="Fig5">5C,D,E</xref>). On the TST, <italic>FAM19A1</italic> −/− mice displayed lower immobility than WT mice (Fig. <xref ref-type="fig" rid="Fig5">5F</xref>). It should be noted that <italic>FAM19A1</italic> −/− mice consistently exhibited a significant increase in basal locomotor activity than WT mice. Thus, anxiety and depression were unable to be determined in these behavior tests. These findings indicate that FAM19A1 ablation is associated with hyperactive behavior.<fig id="Fig5"><label>Figure 5</label><caption><p>Hyperactive behavior in <italic>FAM19A1</italic> −/− mice. (<bold>A</bold>) Time in the open arm (F(2, 32) = 6.469, <italic>p</italic> = 0.0044) and (<bold>B</bold>) total distance (F(2, 32) = 7.803, <italic>p</italic> = 0.0017) were measured in the elevated plus maze (EPM) test in WT (n = 15), <italic>FAM19A1</italic> +/− (n = 11) and <italic>FAM19A1</italic> −/− (n = 9) mice. (<bold>C</bold>) Time in the center and (<bold>D</bold>) total distance (F(2, 43) = 14.50, <italic>p</italic> &lt; 0.0001) were measured in the open field test (OFT) in WT (n = 19), <italic>FAM19A1</italic> +/− (n = 9) and <italic>FAM19A1</italic> −/− (n = 18) mice. (<bold>E</bold>) Simple line tracings of movements in the OFT arena. (<bold>F</bold>) Percentage of immobile time (F(2, 36) = 5.478, <italic>p</italic> = 0.0084) on the tail suspension test (TST) in WT (n = 17), <italic>FAM19A1</italic> +/− (n = 11) and <italic>FAM19A1</italic> −/− (n = 11) mice. (<bold>G</bold>) Spontaneous alteration and (H) total distance (F(2, 34) = 8.257, <italic>p</italic> = 0.0012) on the Y-maze in WT (n = 16), <italic>FAM19A1</italic> +/− (n = 9) and <italic>FAM19A1</italic> −/− (n = 12) mice. Data are presented as means ± standard errors of the means (SEM). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 vs WT or <italic>FAM19A1</italic> +/− by one-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> tests.</p></caption><graphic id="d29e1130" xlink:href="41598_2020_60266_Fig5_HTML"></graphic></fig></p>
</sec>
<sec id="Sec8">
<title>Long-term memory deficits in <italic>FAM19A1</italic> −/− mice</title>
<p id="Par21">Short-term memory (STM), and in particular spatial working memory, is known to involve an interaction between CA1 and CA3 of the hippocampus and the CEn<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, where FAM19A1 is highly expressed (Fig. <xref ref-type="fig" rid="Fig3">3F,J</xref>). On the Y-maze, a spatial working memory test, no significant differences in spontaneous alteration were observed between <italic>FAM19A1</italic> −/− and WT mice (Fig. <xref ref-type="fig" rid="Fig5">5G</xref>). However, the total distance travelled was significantly increased in <italic>FAM19A1</italic> −/− mice, which is consistent with findings on the EPM and OFT, confirming the presence of hyperactive behavior in <italic>FAM19A1</italic> −/− mice (Fig. <xref ref-type="fig" rid="Fig5">5H</xref>).</p>
<p id="Par22">Novel object recognition (NOR) tests were performed to examine possible deficits in object recognition memory. On the short-term memory version of the NOR test, there was no significant difference in preference towards novel objects between <italic>FAM19A1</italic> −/− and WT mice (Fig. <xref ref-type="fig" rid="Fig6">6B,C</xref>). However, on the long-term memory (LTM) version of the NOR test, <italic>FAM19A1</italic> −/− mice exhibited lower preference towards novel objects and higher preference for familiar objects than WT mice (Fig. <xref ref-type="fig" rid="Fig6">6E,F</xref>). These findings indicate that <italic>FAM19A1</italic> −/− mice had lower ability to discriminate between familiar and novel objects 24 hours after acquisition, indicating possible deficits in LTM in <italic>FAM19A1</italic> −/− mice. In addition, <italic>FAM19A1</italic> −/− mice tended to spend more time exploring the objects, regardless of whether the object was novel or familiar, than WT mice (Fig. <xref ref-type="fig" rid="Fig6">6A,D</xref>). This finding may be related to the hyperactive behavior of <italic>FAM19A1</italic> −/−mice, as they may encounter the objects more frequently.<fig id="Fig6"><label>Figure 6</label><caption><p>Short-term and long-term memory in <italic>FAM19A1</italic> −/− mice. (<bold>A</bold>) Time spent on exploration (F(2, 29) = 5.088, <italic>p</italic> = 0.0128), (<bold>B</bold>) object preference and (<bold>C</bold>) the discrimination index on the short-term memory novel object recognition (NOR) test in WT (n = 13), <italic>FAM19A1</italic> +/− (n = 8) and <italic>FAM19A1</italic> −/− (n = 11) mice. (<bold>D</bold>) Time spent on exploration (F(2, 37) = 5.159, <italic>p</italic> = 0.0106), (<bold>E</bold>) object preference (F(2, 38) = 5.531, <italic>p</italic> = 0.0078) and (<bold>F</bold>) the discrimination index (F(2, 37) = 3.870, <italic>p</italic> = 0.0298) on the long-term memory NOR test for WT (n = 11), <italic>FAM19A1</italic> +/− (n = 18) and <italic>FAM19A1</italic> −/− (n = 11) mice. Data are presented as means ± standard errors of the means (SEM). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 versus WT or <italic>FAM19A1</italic> +/− by one-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> tests.</p></caption><graphic id="d29e1263" xlink:href="41598_2020_60266_Fig6_HTML"></graphic></fig></p>
</sec>
<sec id="Sec9">
<title>Impairment of conditioned fear acquisition in <italic>FAM19A1</italic> −/− mice</title>
<p id="Par23">A Pavlovian fear conditioning test was employed to investigate the fear response in <italic>FAM19A1</italic> −/− mice. <italic>FAM19A1</italic> is expressed in fear processing-related areas such as the amygdala and the hippocampus (Fig. <xref ref-type="fig" rid="Fig3">3F,G</xref>)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, which suggests that FAM19A1 may be involved in fear processing. During the fear acquisition phase, <italic>FAM19A1</italic> −/− mice exhibited less freezing behavior than WT mice (Fig. <xref ref-type="fig" rid="Fig7">7A</xref>) such that fear conditioning was not properly induced; <italic>FAM19A1</italic> −/− mice therefore also exhibited less freezing behavior during the subsequent contextual and auditory memory tests (Fig. <xref ref-type="fig" rid="Fig7">7B,C</xref>).<fig id="Fig7"><label>Figure 7</label><caption><p>Fear responses in <italic>FAM19A1</italic> −/− mice. (<bold>A</bold>–<bold>C</bold>) Pavlovian fear conditioning test. (<bold>A</bold>) Fear conditioning during the acquisition phase; F(1, 85) = 53.68, <italic>p</italic> &lt; 0.0001 across genotypes. (<bold>B</bold>) Contextual and (<bold>C</bold>) auditory memory tests were performed 24 h after the acquisition phase in WT (n = 9), and <italic>FAM19A1</italic> −/− (n = 8) mice. (<bold>D</bold>) The innate fear test was performed using synthetic fox feces odor, 2,5-dihydro-2,4,5-trimethylthiazoline (TMT) in WT (n = 8) and <italic>FAM19A1</italic> −/− (n = 10) mice. Data are presented as means ± standard errors of the means (SEM). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 versus WT by two-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> test or Student’s <italic>t</italic> test.</p></caption><graphic id="d29e1353" xlink:href="41598_2020_60266_Fig7_HTML"></graphic></fig></p>
<p id="Par24">It was hypothesized that this lack of fear acquisition in <italic>FAM19A1</italic> −/− mice might be related to the innate fear response. In general, mice innately experience fear when they encounter the smell of their predator’s odor. To test this innate fear response, <italic>FAM19A1</italic> −/− and WT mice were exposed to 2,5-dihydro-2,4,5-trimethylthiazoline (TMT), a component of fox feces. <italic>FAM19A1</italic> −/− mice exhibited the same magnitude of fear response as WT mice over the entire TMT exposure (Fig. <xref ref-type="fig" rid="Fig7">7D</xref>), indicating that the innate fear response remained intact in <italic>FAM19A1</italic> −/− mice. This finding suggests that the inability of <italic>FAM19A1</italic> −/− mice to acquire a conditioned fear response is not related to the innate fear response, but instead may involve other mechanisms such as sensory dysfunctions that prevent <italic>FAM19A1</italic> −/− mice from forming an association between conditioned and unconditioned stimuli.</p>
</sec>
</sec>
<sec id="Sec10" sec-type="discussion">
<title>Discussion</title>
<p id="Par25">FAM19A1 is an evolutionarily conserved secretory polypeptide, which implies that FAM19A1 plays a critical role in the CNS, where it is primarily expressed<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. In this study, a knock-in mouse expressing β-galactosidase via the <italic>FAM19A1</italic> promotor was utilized to map the expression pattern of <italic>FAM19A1</italic> to understand the putative functions of FAM19A1 in both developing and mature brains. <italic>FAM19A1</italic> was expressed in the brain starting during the embryonic stage and continued to be expressed in postnatal and adult brains. In the adult brain, <italic>FAM19A1</italic> was expressed in the pyramidal neurons across the entire neocortex and in various limbic regions. In addition, mice deficient in FAM19A1 exhibited hyperactive behavior and long-term memory deficits and were unable to acquire a conditioned fear response. These findings indicate that FAM19A1 may play important roles in both brain development and function.</p>
<p id="Par26">During the CNS developmental stages, <italic>FAM19A1</italic> expression was observed in the CPf as early as E14.5. As the brain matured, <italic>FAM19A1</italic> expression gradually expanded to the entire neocortex and at the late development, it was also observed in the cingulate cortex (Cg) and the retrosplenial cortex (RSC). The CPf is known to mature faster than other cortical areas whereas the Cg and the RSC are known to mature at relatively later stages of CNS development<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>, suggesting that FAM19A1 may be related to the structural maturation of the developing brain. The postnatal period is when neurogenesis and neuronal migration are almost completed and cortical layer development and synaptogenesis are actively in progress<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Cortical layers are constructed in the inside-out manner<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and <italic>FAM19A1</italic> expression was observed earlier in neurons of L5 compared to neurons of L2-3. Thus, it is assumed that FAM19A1 is expressed in the neurons that are undergoing the maturation process.</p>
<p id="Par27">In the anxiety-related amygdala circuitry, the basolateral nuclei receive incoming stimuli from other limbic areas, including the prefrontal cortex and the thalamus. This information is then sent to the central nucleus of the amygdala (CeA) via glutamatergic connections for further processing<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. <italic>FAM19A1</italic> was expressed exclusively in the basolateral nuclei, and the majority of neurons in these nuclei are pyramidal efferent neurons<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>; thus, FAM19A1 may be mainly secreted by excitatory pyramidal neurons. Moreover, the cortical layer-specific gene expressions are mostly found among the neurons and these molecular identities are often related to the neuronal types<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. In this study, <italic>FAM19A1</italic> expressing cortical cell types were identified to be the pyramidal neurons and this finding is consistent with open-source data from single cell-based RNA-sequencing of WT mouse brain, which reports that the majority of <italic>FAM19A1</italic>-expressing cell types are excitatory neurons<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.</p>
<p id="Par28">The brain receives sensory inputs and processes them into a construct that can be utilized as information via neuronal circuits. Based on the expression pattern of FAM19A1 in the adult mouse brain, FAM19A1 may participate in several sensory information transducing processes. In the olfaction circuit, <italic>FAM19A1</italic> was expressed in most of the olfactory-related brain regions, including the AO, the CPf, the cortical amygdala and the lateral CEn, but was not expressed in the olfactory bulb, where sensory information is initially received<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. For the visual circuit, <italic>FAM19A1</italic> was expressed in the Op, an intermediate zone where axons from the optic tract meet the visual cortical connection, but was not expressed in the optic tract itself<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Moreover, in the auditory circuit, <italic>FAM19A1</italic> was identified in the DC, where all auditory nerve fibers from the cochlea form their first synapses<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. These findings imply that FAM19A1 may not be involved in processes related to receiving sensory stimuli, but instead may be related to intermediate information transduction or information processing.</p>
<p id="Par29">One prominent feature of <italic>FAM19A1</italic> −/− mice was low body weight compared to WT mice. There was no notable difference in the gross appearance between newborn <italic>FAM19A1</italic> −/− and WT mice. Thus, <italic>FAM19A1</italic> −/− mice were able to develop normally in the uterus of <italic>FAM19A1</italic> +/− mothers with WT siblings. One possible explanation for low body weight in <italic>FAM19A1</italic> −/− mice may be abnormal dietary and energy balance. Recently, alteration of food intake behavior was reported in male <italic>FAM19A1</italic> ablated mice, suggesting a potential role of FAM19A1 as a metabolic neurokine in a sex-dependent manner<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. <italic>FAM19A1</italic> was expressed in the VMH which is known to be involved in food intake behaviors and energy homeostasis<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. The neurons in the VMH are predominantly glutamatergic<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, and it has been reported that defects in the glutamatergic leptin receptor-expressing neurons of the VMH are associated with weight change due to thermogenic-related altered energy expenditure<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Thus, low body weight in <italic>FAM19A1</italic> −/− mice may be related to the abnormal activity of these glutamatergic neurons in the VMH. Moreover, the hyperactive behavior observed in <italic>FAM19A1</italic> −/− mice, which requires more energy, may contribute to low body weight.</p>
<p id="Par30">The confinement of <italic>FAM19A1</italic> expression to the limbic system suggests that FAM19A1 may be important to limbic system-related functions, such as emotional and memory processing<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. According to previous studies, the long-term potentiation of synaptic plasticity in the basolateral amygdala is important for stabilization of fear memory consolidation<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. The ablation of FAM19A1, which is expressed in the basolateral amygdala, resulted in an inability to acquire a conditioned fear response. One explanation is that FAM19A1 may play a role in maintaining synaptic plasticity in this region. Another explanation is that FAM19A1-deficient mice could not acquire the fear response due to impairments in the auditory or other sensory systems, as <italic>FAM19A1</italic> was also expressed in the DC and dorsal root ganglia (Supplementary Fig. <xref ref-type="media" rid="MOESM1">S5F,N</xref>). Additional phenotypic analysis of <italic>FAM19A1</italic> −/− mice is needed, including hearing and other sensory tests. In addition to that, synaptic plasticity in <italic>FAM19A1</italic> −/− mice needs to be investigated.</p>
<p id="Par31">Memory is a fundamental brain function and is controlled mainly by the limbic system. Once external information is received, it is initially encoded as STM. This STM is then converted into LTM via memory consolidation<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. In <italic>FAM19A1</italic> −/− mice, STM formation seems to be remained intact, but LTM appeared to be affected, as <italic>FAM19A1</italic> −/− mice were unable to distinguish novel objects from familiar objects. This finding implies that FAM19A1 may not be involved in the memory encoding process, but instead may participate in the memory consolidation process to generate LTM. Memory consolidation requires changes in synaptic remodeling, which leads to the long-term potentiation that maintains synaptic plasticity for memory formation<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. The absence of FAM19A1 may contribute to abnormalities in synaptic function, resulting in a failure to form LTM. This hypothetical explanation suggests that FAM19A1 may be involved in the long-term potentiation process.</p>
<p id="Par32">Another behavioral phenotype displayed by <italic>FAM19A1</italic> −/− mice was hyperactivity. Hyperactivity is closely linked to the human neurodevelopmental disorder called, ADHD. Although the pathophysiological and molecular mechanisms of ADHD remain poorly understood, there have been several studies suggesting that patients with ADHD have compromised brain connectivity, particularly in the corpus callosum and the corticospinal tract, which contributes to dysfunctional communication in the superior longitudinal fasciculus and the cortico-limbic areas<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. <italic>FAM19A1</italic> was expressed in the cortical L5 pyramidal neurons as well as the cortico-spinal tract across the entire neocortex, which project their axons to other brain areas to form several crucial brain connections. This expression pattern implies that the absence of FAM19A1 may alter the functional plasticity of the neurons, which may lead to dysfunctional brain connectivity resulting in hyperactive behavior.</p>
<p id="Par33">In the open-source collective RNA-sequencing database, ARCHS4 (All RNA-seq and ChIP-seq sample and signature search), the highest predicted biological function of FAM19A1 is presynaptic and/or postsynaptic membrane assembly, and the highest predicted mouse phenotypes associated with FAM19A1 were abnormal central patterns, synaptic plasticity and abnormal learning and memory<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Some of these predicted biological functions and phenotypes are consistent with the phenotypes observed in <italic>FAM19A1</italic> −/− mice in this study at limited extend. In particular, abnormal synaptic plasticity may be associated with the hyperactive behavior and long-term memory deficits we observed in <italic>FAM19A1</italic> −/− mice<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. In the genome-wide association for human genetic variants database, GWASdb, FAM19A1 was identified to be associated with ADHD<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. In addition, there have been human case reports that patients with 3p14.1 interstitial deletion, where the <italic>FAM19A1</italic> gene is located, exhibited intellectual disability, and in some cases, autistic features<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. Although this chromosomal position also contains other neurodevelopment-related genes, such as FOXP1, it is still rationally deduced that the ablation of FAM19A1, starting from the developmental stages may contribute to hyperactive symptom generation.</p>
<p id="Par34">In summary, as a CNS-specific secretory polypeptide, the <italic>FAM19A1</italic> gene was expressed starting in the early embryonic period within restricted brain areas and gradually expanded to all neocortical areas as well as areas of the limbic system during the postnatal period. Based on this expression pattern, the major <italic>FAM19A1</italic>-expressing cell type was suspected to be excitatory pyramidal neurons. In addition, FAM19A1-deficient mice exhibited hyperactive behavior, long-term memory deficits, and an inability to acquire a conditioned fear response, suggesting that FAM19A1 may be involved in synaptic plasticity and long-term potentiation. Given the involvement of FAM19A1 in human case reports of neurodevelopmental disorders, we conclude that FAM19A1 may play important roles in both neurodevelopment and brain function.</p>
</sec>
<sec id="Sec11" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="Sec12">
<title>Animals and handling</title>
<p id="Par35">All mice were housed in a temperature-controlled (22~23 °C) facility under a 12:12 light:dark photoperiod (lights on at 8:00am), with ad lib access to standard mouse chow and water. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Korea University (KOREA-2016-0091) and performed in accordance with guidelines and regulations of IACUC of Korea University.</p>
<p id="Par36">The <italic>FAM19A1 LacZ</italic> knock-in (KI) mouse was generated at the University of California, Davis, Mouse Biology Program (MBP)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. In brief, the <italic>LacZ</italic> sequence containing the target vector (Fig. <xref ref-type="fig" rid="Fig1">1A</xref>) was constructed and inserted into embryonic stem (ES) cells via electroporation. Target vector incorporation was validated by genotyping and chromosome counting of the transgenic ES cells. The confirmed transgenic ES cells were injected into blastocysts and transferred to the uterus of a female recipient mouse. A germline transmission test was performed to confirm chimeric generation. The generated <italic>FAM19A1 LacZ</italic> KI chimeric mice were backcrossed onto C57BL/6J genetic background. The <italic>FAM19A1 LacZ</italic> KI strain was maintained by mating heterozygous <italic>FAM19A1 LacZ</italic> KI male mice with WT C57BL/6J female mice (Maine, United States). To obtain homozygous <italic>FAM19A1 LacZ</italic> KI mice, heterozygous <italic>FAM19A1 LacZ</italic> KI male mice were mated with heterozygous <italic>FAM19A1 LacZ</italic> KI female mice. Genotyping was performed using the following primers: FWT dn1: 5′ TCG CAC AAG CAC TTA TCC AC 3′, FKI dn2: 5′ ATC TGA GTT GCT GGC TTG GT 3′ and F UP1: 5′ AGC TTC TGG GAA AGG TCT TCA 3′.</p>
</sec>
<sec id="Sec13">
<title>X-gal staining for embryonic and postnatal brains</title>
<p id="Par37">X-gal staining was conducted as previously described<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. For embryonic X-gal staining, pregnant mice were sacrificed by cervical dislocation and the embryos were isolated. Whole embryos at E12.5 were fixed in 4% PFA and 0.2% glutaraldehyde (GTA) in PBS for 15 min at 4 °C. For embryos and postnatal mice older than E14.5, the heads were cut and the skins were removed. The heads of the embryos were fixed for 1~2 h at 4 °C. The postnatal brains were isolated from the skulls and fixed for 1~2 h at 4 °C. The fixed tissues were then washed with PBS twice for 5 min and incubated in X-gal staining solution (1 mg/ml of X-gal, 2 mM MgCl<sub>2</sub>, 5 mM EGTA, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 0.01% sodium deoxycholate, and 0.02% Nonidet-P40 in 0.1 M phosphate buffer (PB) at pH 7.3) for 24–48 h in darkness at 37 °C. The stained tissues were post-fixed with 4% PFA in PBS overnight at 4 °C, and washed with PBS, then whole brain images were obtained. The stained whole brains were cryo-protected with 30% sucrose in phosphate-buffered saline (PBS). and cut into 40-μm sections using Cryostat (Leica, Wetzlar, Germany). Nuclear Fast Red (H-3403, VECTOR, California, United States) was used as a counter-stain where appropriate. Images of the sections were taken using a slide-scanner (Axio scan Z1, Zeiss, Oberkochen, Germany).</p>
</sec>
<sec id="Sec14">
<title>X-gal staining for adult brains, spinal cords and dorsal root ganglia</title>
<p id="Par38">X-gal staining was performed as previously described<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Adult mice (8–12 weeks old) were perfused with 4% PFA and 0.2% GTA in PB. The brains, spinal cords and dorsal root ganglia were isolated and post-fixed in 0.2% GTA in PB for 12 h at 4 °C.The tissues were then cryo-protected in 30% sucrose in PBS and serially cross-sectioned into 40-μm sections using Cryostat (Leica). The sectioned tissues then were incubated in the X-gal staining solution for 24–48 h at 37 °C in darkness. Images of the sections were taken using a slide-scanner (Axio scan Z1, Zeiss).</p>
</sec>
<sec id="Sec15">
<title>Immunohistochemical analysis</title>
<p id="Par39">Animals were perfused with 4% paraformaldehyde (PFA) in (PBS). The isolated brains were post-fixed overnight. The brains were then cryo-protected in 30% sucrose in PBS and serially cross-sectioned into 40-μm sections using Cryostat (Leica) The sections were blocked with 3% bovine serum albumin (BSA) and 0.1% Triton X-100 in PBS for 30 min at room temperature. Primary antibodies were applied overnight at 4 °C and then the appropriate fluorescent conjugated secondary antibodies were applied with Hoechst 33342 (Invitrogen, California, United States) for 30 min at room temperature. For immunohistochemistry on X-gal stained tissues<sup><xref ref-type="bibr" rid="CR59">59</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>, the brain tissues were initially stained in X-gal staining solution and then washed in PBS. Normal immunohistochemistry procedures were carried out with X-gal stained tissues. For image acquisition, X-gal precipitates were excited at 633 nm and the fluorescence signals were detected at 650–770 nm. The following antibodies were used: β-galactosidase (1:500; ab9391, abcam, Cambridge, United Kingdom); anti-CTIP2 (1:500; ab18465, abcam); anti-CUX1 (1:500; SC-13024, Santa Cruz, Texas, United States); anti-GFAP (1:500; Z0334, DAKO, California, United States); anti-Iba1 (1:500; 019-19741, Wako, Osaka, Japan); anti-Olig2 (1:500; AB9610, Millipore, Massachusetts, United States); and fluorescent conjugated anti-rabbit, anti-rat and anti-chick (1:500; Life technologies, California, United States). Images were obtained using a confocal microscope (TCS SP8, Leica).</p>
</sec>
<sec id="Sec16">
<title>Nissl staining</title>
<p id="Par40">Animals were perfused with 4% PFA in PBS. The brains were isolated and post-fixed overnight. The brains were then cryo-protected in 30% sucrose in PBS and serially cross-sectioned into 40-μm sections using Cryostat (Leica). The brain sections were dipped in a Nissl stain solution, 1% w/v Cresyl Violet (C5042, Sigma-Aldrich, Missouri, United states) and 1% v/v glacial acetic acid at 50 °C for 5 to 10 min. After a wash with distilled water, the tissues were differentiated in ethyl alcohol for 10 to 20 min. The dehydrated tissues were cleared in xylene and mounted with Permount (SP15-500, Thermo Fisher Scientific, Massachusetts, United States). The images of the sections were taken using a slide-scanner (Axio scan Z1, Zeiss).</p>
<p id="Par41">See the Supplementary Information for details on the generation of the polyclonal anti-FAM19A1 antibody, western blot analysis, reverse transcription PCR<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, <italic>in situ</italic> hybridization, body weight measurement, whole-brain size measurement, cerebral cortex analysis with unbiased stereology<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, cortical thickness measurement<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup> and neuronal and glial cell density analysis<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup>.</p>
</sec>
<sec id="Sec17">
<title>Behavior analysis</title>
<p id="Par42">Before commencing the behavioral tests, all male mice (8–12 weeks old) were handled for 5 min daily for 3 days to habituate them to the hands of the test instructor. See the Supplementary Information for details on the elevated plus maze (EPM) test, open field test (OFT), tail suspension test (TST), Y-maze, novel object recognition (NOR) test, Pavlovian fear conditioning and unconditioned innate fear response, which were performed as previously described<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>.</p>
</sec>
<sec id="Sec18">
<title>Statistical analysis</title>
<p id="Par43">All statistical analysis was performed using GraphPad Prism 5 (GraphPad Software Inc., California, United States) and the data are shown as means ± standard errors of the means (SEM). Statistical significance was evaluated using Student’s <italic>t</italic> tests and/or one-way or two-way analysis of variance (ANOVA) with Bonferroni <italic>post hoc</italic> tests. A <italic>p-</italic>value less than 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec19">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2020_60266_MOESM1_ESM.pdf"><caption><p>Supplementary Information.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>is available for this paper at 10.1038/s41598-020-60266-1.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by a grant from the Research Program of the National Research Foundation of Korea (NRF-2016R1A2B1010036), which is funded by the Ministry of Science, ICT, and Future Planning. This work involves a U.S. patent (62/748,864) held by Neuracle Science Co. Ltd.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>H.J.Y., H.K., J.-I.H. and J.Y.S. designed the research. H.J.Y. and N.H. performed the experiments. H.J.Y., E.B.C. and S.Y. analyzed the data. H.J.Y., J.-I.H. and J.Y.S. wrote the manuscript.</p>
</notes>
<notes notes-type="data-availability">
<title>Data availability</title>
<p>All data are available from the GPCR laboratory of Korea University, and there are no restrictions on data availability.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par44">H.J.Y., S.Y., H.K., J.-I.H., and J.Y.S. are shareholders of Neuracle Science Co. Ltd. and N.H. and E.B.C. are employees and shareholders of Neuracle Science Co. Ltd. The authors declare that there are no other conflicts of interest.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Englund</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex</article-title>
<source/>The Journal of neuroscience: the official journal of the Society for Neuroscience
          <year>2005</year>
<volume>25</volume>
<fpage>247</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.2899-04.2005</pub-id>
<pub-id pub-id-type="pmid">15634788</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Telley</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequential transcriptional waves direct the differentiation of newborn neurons in the mouse neocortex</article-title>
<source/>Science (New York, N.Y.)
          <year>2016</year>
<volume>351</volume>
<fpage>1443</fpage>
<lpage>1446</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad8361</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villeda</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The ageing systemic milieu negatively regulates neurogenesis and cognitive function</article-title>
<source/>Nature
          <year>2011</year>
<volume>477</volume>
<fpage>90</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1038/nature10357</pub-id>
<pub-id pub-id-type="pmid">21886162</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secreted frizzled-related protein 3 regulates activity-dependent adult hippocampal neurogenesis</article-title>
<source/>Cell stem cell
          <year>2013</year>
<volume>12</volume>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.11.021</pub-id>
<pub-id pub-id-type="pmid">23395446</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>WJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism</article-title>
<source/>The Journal of neuroscience: the official journal of the Society for Neuroscience
          <year>2015</year>
<volume>35</volume>
<fpage>10343</fpage>
<lpage>10356</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.0584-15.2015</pub-id>
<pub-id pub-id-type="pmid">26180209</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deverman</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Cytokines and CNS development</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<fpage>61</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.002</pub-id>
<pub-id pub-id-type="pmid">19840550</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chojnacki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shimazaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gregg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Weinmaster</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Glycoprotein 130 signaling regulates Notch1 expression and activation in the self-renewal of mammalian forebrain neural stem cells</article-title>
<source/>The Journal of neuroscience: the official journal of the Society for Neuroscience
          <year>2003</year>
<volume>23</volume>
<fpage>1730</fpage>
<lpage>1741</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-05-01730.2003</pub-id>
<pub-id pub-id-type="pmid">12629177</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differentiation of neural progenitor cells in a microfluidic chip-generated cytokine gradient</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2009</year>
<volume>27</volume>
<fpage>2646</fpage>
<lpage>2654</lpage>
<pub-id pub-id-type="doi">10.1002/stem.202</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieberam</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Agalliu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ericson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons</article-title>
<source/>Neuron
          <year>2005</year>
<volume>47</volume>
<fpage>667</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.011</pub-id>
<pub-id pub-id-type="pmid">16129397</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyasaka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Knaut</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Cxcl12/Cxcr4 chemokine signaling is required for placode assembly and sensory axon pathfinding in the zebrafish olfactory system</article-title>
<source/>Development (Cambridge, England)
          <year>2007</year>
<volume>134</volume>
<fpage>2459</fpage>
<lpage>2468</lpage>
<pub-id pub-id-type="doi">10.1242/dev.001958</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs</article-title>
<source/>Journal of neurochemistry
          <year>1991</year>
<volume>56</volume>
<fpage>2147</fpage>
<lpage>2150</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1991.tb03479.x</pub-id>
<pub-id pub-id-type="pmid">1902872</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamber</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Hoyle</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Brinster</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Palmiter</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>1994</year>
<volume>91</volume>
<fpage>7839</fpage>
<lpage>7843</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.91.17.7839</pub-id>
<pub-id pub-id-type="pmid">7914698</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A neuromodulatory role of interleukin-1beta in the hippocampus</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>1998</year>
<volume>95</volume>
<fpage>7778</fpage>
<lpage>7783</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.95.13.7778</pub-id>
<pub-id pub-id-type="pmid">9636227</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zunszain</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>37</volume>
<fpage>939</fpage>
<pub-id pub-id-type="doi">10.1038/npp.2011.277</pub-id>
<pub-id pub-id-type="pmid">22071871</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>L-W</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders</article-title>
<source/>Neural Regen Res
          <year>2017</year>
<volume>12</volume>
<fpage>366</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.202926</pub-id>
<pub-id pub-id-type="pmid">28469641</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Han, Y. M. Y. <italic>et al</italic>. Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders. <italic>Frontiers in Immunology</italic><bold>8</bold>, 10.3389/fimmu.2017.00011 (2017).</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tom Tang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TAFA: a novel secreted family with conserved cysteine residues and restricted expression in the brain</article-title>
<source/>Genomics
          <year>2004</year>
<volume>83</volume>
<fpage>727</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygeno.2003.10.006</pub-id>
<pub-id pub-id-type="pmid">15028294</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted knockout of a chemokine-like gene increases anxiety and fear responses</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2018</year>
<volume>115</volume>
<fpage>E1041</fpage>
<lpage>e1050</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1707663115</pub-id>
<pub-id pub-id-type="pmid">29339520</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tafa-2 plays an essential role in neuronal survival and neurobiological function in mice</article-title>
<source/>Acta biochimica et biophysica Sinica
          <year>2018</year>
<volume>50</volume>
<fpage>984</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="doi">10.1093/abbs/gmy097</pub-id>
<pub-id pub-id-type="pmid">30137205</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ariyasiri</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pharmacological (ethanol) and mutation (sam2 KO) induced impairment of novelty preference in zebrafish quantified using a new three-chamber social choice task</article-title>
<source/>Progress in neuro-psychopharmacology &amp; biological psychiatry
          <year>2019</year>
<volume>88</volume>
<fpage>53</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.06.009</pub-id>
<pub-id pub-id-type="pmid">29958859</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delfini</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TAFA4, a chemokine-like protein, modulates injury-induced mechanical and chemical pain hypersensitivity in mice</article-title>
<source/>Cell reports
          <year>2013</year>
<volume>5</volume>
<fpage>378</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.09.013</pub-id>
<pub-id pub-id-type="pmid">24139797</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kambrun</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TAFA4 Reverses Mechanical Allodynia through Activation of GABAergic Transmission and Microglial Process Retraction</article-title>
<source/>Cell reports
          <year>2018</year>
<volume>22</volume>
<fpage>2886</fpage>
<lpage>2897</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.068</pub-id>
<pub-id pub-id-type="pmid">29539418</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficiency of a brain-specific chemokine-like molecule, SAM3, induces cardinal phenotypes of autism spectrum disorders in mice</article-title>
<source/>Scientific reports
          <year>2017</year>
<volume>7</volume>
<fpage>16503</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-16769-5</pub-id>
<pub-id pub-id-type="pmid">29184127</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Can</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Dixin</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Yan</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Yun</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Shiyang</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Danfeng</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Weiwei</given-names>
</name>
<name>
<surname>She</surname>
<given-names>Shaoping</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Xinjian</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Pingzhang</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>Xiaoning</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Quansheng</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Ping</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Jing</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Richard D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Ying</given-names>
</name>
</person-group>
<article-title>FAM19A1 is a new ligand for GPR1 that modulates neural stem‐cell proliferation and differentiation</article-title>
<source/>The FASEB Journal
          <year>2018</year>
<volume>32</volume>
<issue>11</issue>
<fpage>5874</fpage>
<lpage>5890</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201800020RRR</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>Richard J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Hosung</given-names>
</name>
<name>
<surname>Bhangoo</surname>
<given-names>Sonia K.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>Fletcher A.</given-names>
</name>
</person-group>
<article-title>Cytokine and Chemokine Regulation of Sensory Neuron Function</article-title>
<source/>Sensory Nerves
          <year>2009</year>
<publisher-loc>Berlin, Heidelberg</publisher-loc>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<fpage>417</fpage>
<lpage>449</lpage>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruol</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>IL-6 regulation of synaptic function in the CNS</article-title>
<source/>Neuropharmacology
          <year>2015</year>
<volume>96</volume>
<fpage>42</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.10.023</pub-id>
<pub-id pub-id-type="pmid">25445486</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonini</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice</article-title>
<source/>Cerebral cortex (New York, N.Y.: 1991)
          <year>2016</year>
<volume>26</volume>
<fpage>2832</fpage>
<lpage>2849</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhw037</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeisel</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular Architecture of the Mouse Nervous System</article-title>
<source/>Cell
          <year>2018</year>
<volume>174</volume>
<fpage>999</fpage>
<lpage>1014.e1022</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.06.021</pub-id>
<pub-id pub-id-type="pmid">30096314</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jolkkonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Miettinen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Projections from the amygdalo-piriform transition area to the amygdaloid complex: A PHA-l study in rat</article-title>
<source/>Journal of Comparative Neurology
          <year>2001</year>
<volume>432</volume>
<fpage>440</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1002/cne.1113</pub-id>
<pub-id pub-id-type="pmid">11268008</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback</article-title>
<source/>American journal of physiology. Regulatory, integrative and comparative physiology
          <year>2007</year>
<volume>293</volume>
<fpage>R83</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.00907.2006</pub-id>
<pub-id pub-id-type="pmid">17459911</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singewald</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Rjabokon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singewald</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ebner</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<fpage>793</fpage>
<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2010.213</pub-id>
<pub-id pub-id-type="pmid">21160468</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fame</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Dunwoodie</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Macklis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Cited2 Regulates Neocortical Layer II/III Generation and Somatosensory Callosal Projection Neuron Development and Connectivity</article-title>
<source/>The Journal of neuroscience: the official journal of the Society for Neuroscience
          <year>2016</year>
<volume>36</volume>
<fpage>6403</fpage>
<lpage>6419</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.4067-15.2016</pub-id>
<pub-id pub-id-type="pmid">27307230</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardinal</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Parkinson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Everitt</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex</article-title>
<source/>Neuroscience &amp; Biobehavioral Reviews
          <year>2002</year>
<volume>26</volume>
<fpage>321</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/S0149-7634(02)00007-6</pub-id>
<pub-id pub-id-type="pmid">12034134</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rivest</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Nakashiba</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Entorhinal Cortex Layer III Input to the Hippocampus Is Crucial for Temporal Association Memory</article-title>
<source/>Science (New York, N.Y.)
          <year>2011</year>
<volume>334</volume>
<fpage>1415</fpage>
<pub-id pub-id-type="doi">10.1126/science.1210125</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>LeDoux</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning</article-title>
<source/>Behavioral neuroscience
          <year>1992</year>
<volume>106</volume>
<fpage>274</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.106.2.274</pub-id>
<pub-id pub-id-type="pmid">1590953</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klingler</surname>
<given-names>Esther</given-names>
</name>
</person-group>
<article-title>Development and Organization of the Evolutionarily Conserved Three-Layered Olfactory Cortex</article-title>
<source/>eneuro
          <year>2017</year>
<volume>4</volume>
<issue>1</issue>
<fpage>ENEURO.0193-16.2016</fpage>
<pub-id pub-id-type="doi">10.1523/ENEURO.0193-16.2016</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomiak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Mechanisms of Hierarchical Cortical Maturation</article-title>
<source/>Front Cell Neurosci
          <year>2017</year>
<volume>11</volume>
<fpage>272</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00272</pub-id>
<pub-id pub-id-type="pmid">28959187</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farhy-Tselnicker</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Astrocytes, neurons, synapses: a tripartite view on cortical circuit development</article-title>
<source/>Neural development
          <year>2018</year>
<volume>13</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/s13064-018-0104-y</pub-id>
<pub-id pub-id-type="pmid">29712572</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molyneaux</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Arlotta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Menezes</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Macklis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Neuronal subtype specification in the cerebral cortex</article-title>
<source/>Nature reviews. Neuroscience
          <year>2007</year>
<volume>8</volume>
<fpage>427</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2151</pub-id>
<pub-id pub-id-type="pmid">17514196</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tye</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amygdala circuitry mediating reversible and bidirectional control of anxiety</article-title>
<source/>Nature
          <year>2011</year>
<volume>471</volume>
<fpage>358</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1038/nature09820</pub-id>
<pub-id pub-id-type="pmid">21389985</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Mascagni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Pyramidal cells of the rat basolateral amygdala: synaptology and innervation by parvalbumin-immunoreactive interneurons</article-title>
<source/>J Comp Neurol
          <year>2006</year>
<volume>494</volume>
<fpage>635</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.1002/cne.20832</pub-id>
<pub-id pub-id-type="pmid">16374802</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belluscio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lodovichi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feinstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mombaerts</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>Odorant receptors instruct functional circuitry in the mouse olfactory bulb</article-title>
<source/>Nature
          <year>2002</year>
<volume>419</volume>
<fpage>296</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1038/nature01001</pub-id>
<pub-id pub-id-type="pmid">12239567</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<mixed-citation publication-type="other">May, P. J. In <italic>Progress in Brain Research</italic> Vol. 151 (ed. Büttner-Ennever, J. A.) 321–378 (Elsevier, 2006).</mixed-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oertel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Joris</surname>
<given-names>PX</given-names>
</name>
</person-group>
<article-title>Detection of synchrony in the activity of auditory nerve fibers by octopus cells of the mammalian cochlear nucleus</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2000</year>
<volume>97</volume>
<fpage>11773</fpage>
<lpage>11779</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.22.11773</pub-id>
<pub-id pub-id-type="pmid">11050208</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>Xia</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Lili</given-names>
</name>
<name>
<surname>Terrillion</surname>
<given-names>Chantelle E.</given-names>
</name>
<name>
<surname>Karuppagounder</surname>
<given-names>Senthilkumar S.</given-names>
</name>
<name>
<surname>Cisternas</surname>
<given-names>Pedro</given-names>
</name>
<name>
<surname>Lay</surname>
<given-names>Mark</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>David C.</given-names>
</name>
<name>
<surname>Aja</surname>
<given-names>Susan</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Xinzhong</given-names>
</name>
<name>
<surname>Pletnikov</surname>
<given-names>Mikhail V.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G. William</given-names>
</name>
</person-group>
<article-title>FAM19A1, a brain-enriched and metabolically responsive neurokine, regulates food intake patterns and mouse behaviors</article-title>
<source/>The FASEB Journal
          <year>2019</year>
<volume>33</volume>
<issue>12</issue>
<fpage>14734</fpage>
<lpage>14747</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201901232RR</pub-id>
<pub-id pub-id-type="pmid">31689372</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhillon</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis</article-title>
<source/>Neuron
          <year>2006</year>
<volume>49</volume>
<fpage>191</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2005.12.021</pub-id>
<pub-id pub-id-type="pmid">16423694</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia</article-title>
<source/>Cell metabolism
          <year>2007</year>
<volume>5</volume>
<fpage>383</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2007.04.001</pub-id>
<pub-id pub-id-type="pmid">17488640</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miserendino</surname>
<given-names>MJD</given-names>
</name>
<name>
<surname>Sananes</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Melia</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala</article-title>
<source/>Nature
          <year>1990</year>
<volume>345</volume>
<fpage>716</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="doi">10.1038/345716a0</pub-id>
<pub-id pub-id-type="pmid">1972778</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eichenbaum</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A cortical–hippocampal system for declarative memory</article-title>
<source/>Nature Reviews Neuroscience
          <year>2000</year>
<volume>1</volume>
<fpage>41</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1038/35036213</pub-id>
<pub-id pub-id-type="pmid">11252767</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamprecht</surname>
<given-names>R</given-names>
</name>
<name>
<surname>LeDoux</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Structural plasticity and memory</article-title>
<source/>Nature Reviews Neuroscience
          <year>2004</year>
<volume>5</volume>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1301</pub-id>
<pub-id pub-id-type="pmid">14708003</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>LS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced white matter integrity in attention-deficit hyperactivity disorder</article-title>
<source/>Neuroreport
          <year>2008</year>
<volume>19</volume>
<fpage>1705</fpage>
<lpage>1708</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e3283174415</pub-id>
<pub-id pub-id-type="pmid">18841089</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes of brain structure and function in ADHD children</article-title>
<source/>Brain topography
          <year>2011</year>
<volume>24</volume>
<fpage>243</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1007/s10548-010-0168-4</pub-id>
<pub-id pub-id-type="pmid">21191807</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lachmann</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Massive mining of publicly available RNA-seq data from human and mouse</article-title>
<source/>Nature communications
          <year>2018</year>
<volume>9</volume>
<fpage>1366</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-03751-6</pub-id>
<pub-id pub-id-type="pmid">29636450</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties</article-title>
<source/>Nature
          <year>2013</year>
<volume>503</volume>
<fpage>72</fpage>
<pub-id pub-id-type="doi">10.1038/nature12630</pub-id>
<pub-id pub-id-type="pmid">24153177</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GWASdb: a database for human genetic variants identified by genome-wide association studies</article-title>
<source/>Nucleic acids research
          <year>2012</year>
<volume>40</volume>
<fpage>D1047</fpage>
<lpage>1054</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkr1182</pub-id>
<pub-id pub-id-type="pmid">22139925</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Hoz</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>3p14 <italic>De Novo</italic> Interstitial Microdeletion in a Patient with Intellectual Disability and Autistic Features with Language Impairment: A Comparison with Similar Cases</article-title>
<source/>Case reports in genetics
          <year>2015</year>
<volume>2015</volume>
<fpage>876348</fpage>
<pub-id pub-id-type="doi">10.1155/2015/876348</pub-id>
<pub-id pub-id-type="pmid">26075115</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitrov</surname>
<given-names>BI</given-names>
</name>
<etal></etal>
</person-group>
<article-title>3p14 deletion is a rare contiguous gene syndrome: report of 2 new patients and an overview of 14 patients</article-title>
<source/>American journal of medical genetics. Part A
          <year>2015</year>
<volume>167</volume>
<fpage>1223</fpage>
<lpage>1230</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36556</pub-id>
<pub-id pub-id-type="pmid">25908055</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skarnes</surname>
<given-names>WC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1038/nature10163</pub-id>
<pub-id pub-id-type="pmid">21677750</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<mixed-citation publication-type="other">Shahapal, A. <italic>et al</italic>. FAM19A5 Expression During Embryogenesis and in the Adult Traumatic Brain of FAM19A5-LacZ Knock-in Mice. <bold>13</bold>, 10.3389/fnins.2019.00917 (2019).</mixed-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levitsky</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Toledo-Aral</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>López-Barneo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Villadiego</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Direct confocal acquisition of fluorescence from X-gal staining on thick tissue sections</article-title>
<source/>Scientific reports
          <year>2013</year>
<volume>3</volume>
<fpage>2937</fpage>
<pub-id pub-id-type="doi">10.1038/srep02937</pub-id>
<pub-id pub-id-type="pmid">24121824</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomczynski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sacchi</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction</article-title>
<source/>Analytical biochemistry
          <year>1987</year>
<volume>162</volume>
<fpage>156</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1006/abio.1987.9999</pub-id>
<pub-id pub-id-type="pmid">2440339</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<mixed-citation publication-type="other">Paxinos, G. <italic>The mouse brain in stereotaxic coordinates</italic>/<italic>George Paxinos, Keith B.J. Franklin</italic> (Academic, 2001).</mixed-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filichia</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Forebrain neuronal specific ablation of p53 gene provides protection in a cortical ischemic stroke model</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>295</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.03.018</pub-id>
<pub-id pub-id-type="pmid">25779964</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spexin-Based Galanin Receptor Type 2 Agonist for Comorbid Mood Disorders and Abnormal Body Weight</article-title>
<source/>Frontiers in neuroscience
          <year>2019</year>
<volume>13</volume>
<fpage>391</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2019.00391</pub-id>
<pub-id pub-id-type="pmid">31057364</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>